Department of Medicine, Wright State University, Dayton, OH 10032, USA.
Anticancer Res. 2010 Dec;30(12):5113-5.
Drug-induced pancreatitis is less common compared to other causes of acute pancreatitis; the incidence ranges from between 0.1% to 2% of acute pancreatitis cases. Among alkylating agents, oxaliplatin has not been reported to be associated with acute pancreatitis.
This case study presents a series of six cases of acute pancreatitis presumably related to exposure to oxaliplatin which had different gastrointestinal malignancies and were being treated with oxaliplatin in combination with other chemotherapeutic drugs. All other related causes of acute pancreatitis were excluded before implicating oxaliplatin as a possible cause.
In all cases, oxaliplatin was stopped and patients had resolution of their signs and symptoms, along with a decrease in serum amylase and lipase levels.
Knowledge regarding acute pancreatitis related to oxaliplatin is of paramount importance in order to diagnose cases early and institute effective treatment in patients who are undergoing chemotherapy with this drug.
与其他急性胰腺炎的病因相比,药物性胰腺炎相对少见;其发病率占急性胰腺炎病例的 0.1%至 2%之间。在烷化剂中,尚未有奥沙利铂与急性胰腺炎相关的报道。
本病例研究报告了一系列 6 例推测与奥沙利铂暴露相关的急性胰腺炎病例,这些患者患有不同的胃肠道恶性肿瘤,并接受奥沙利铂联合其他化疗药物治疗。在将奥沙利铂作为可能的病因之前,排除了所有其他相关的急性胰腺炎病因。
所有患者均停用了奥沙利铂,其症状和体征得到缓解,血清淀粉酶和脂肪酶水平下降。
了解奥沙利铂相关的急性胰腺炎对于早期诊断和对接受该药化疗的患者进行有效治疗至关重要。